Opportunities in the C5 inhibitors market include developing next-gen biosimilars and biosuperiors to improve administration frequency and expand treatment indications for diseases like aHUS, SCD, MG, ...
Thank you, Eva, and thank you all for joining us this morning. Before turning to our fourth quarter results, I would like to ...
NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today released The New Growth Frontier. This new analysis, produced in collaboration with Kearney, reveals that artificial intelligence ...
Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® ...
Cyprus presidency seeks to establish a European centre addressing persistent structural gaps in the EU's HTA health system ...
Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...
NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today released The New Growth Frontier. This new analysis, ...
At the invitation of His Excellency Narendra Modi, Prime Minister of India, the Right Honourable Mark Carney, Prime Minister of Canada, paid an official visit to India from February 27 -- March 2, ...
Read more about Nanoparticle and AI-driven vaccines target broad protection against emerging threats on Devdiscourse ...
Gelatine Sculpt is a liquid dietary supplement positioned as a premium, holistic evolution of the gelatin trick. Marketed as a "Bariatric Jelly" alternative, Gelatine Sculpt is designed to be taken as ...
NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today released The New Growth Frontier. This new analysis, produced in collaboration with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results